Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03239184 | Bioinformation Therapy for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT00789633 | Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer | completed | Phase 3 | 353 | AB ScienceINDUSTRY | 5 | Dec 17, 2018 | clinicaltrials |
| Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy |
| unknown |
| Phase 3 |
| 300 |
| Fudan UniversityOTHER |
| 1 |
| Oct 9, 2018 |
| clinicaltrials |
| NCT01900327 | Neoadjuvant Treatment in Resectable Pancreatic Cancer(NEOPA) | terminated | Phase 3 | 32 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT01458717 | Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer | completed | Phase 2 / Phase 3 | 58 | Seoul National University HospitalOTHER | 1 | May 2, 2018 | clinicaltrials |
| NCT02284139 | Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects | completed | Phase 2 / Phase 3 | 90 | Dong-A University HospitalOTHER | 1 | Apr 23, 2018 | clinicaltrials |
| NCT02119663 | A Study of Ruxolitinib in Pancreatic Cancer Patients | terminated | Phase 3 | 86 | Incyte CorporationINDUSTRY | 14 | Feb 13, 2018 | clinicaltrials |
| NCT00040183 | OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. | completed | Phase 3 | 569 | OSI PharmaceuticalsINDUSTRY | 17 | Jan 10, 2018 | clinicaltrials |
| NCT03317886 | Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer | unknown | Phase 3 | 354 | Wakayama Medical UniversityOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT03251365 | Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 42 | Hospital General de Ciudad RealOTHER | 1 | Aug 16, 2017 | clinicaltrials |
| NCT03200821 | An Open Label Study to Evaluate G17DT Compared to Gemcitabine | completed | Phase 3 | 103 | Cancer Advances Inc.INDUSTRY | 0 | Jun 27, 2017 | clinicaltrials |
| NCT02694536 | A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | completed | Phase 3 | 80 | Hoffmann-La RocheINDUSTRY | 1 | Mar 24, 2017 | clinicaltrials |
| NCT00003049 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | completed | Phase 3 | 100 | Mayo ClinicOTHER | 1 | Dec 22, 2016 | clinicaltrials |
| NCT02988635 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | completed | Phase 3 | 281 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT02854072 | A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients | unknown | Phase 3 | 148 | Samsung Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 22, 2016 | clinicaltrials |
| NCT02871804 | Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy(COSMOS-DP) | unknown | Phase 3 | 304 | Wakayama Medical UniversityOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT02117895 | Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail | unknown | Phase 3 | 180 | Fudan UniversityOTHER | 1 | Aug 11, 2016 | clinicaltrials |
| NCT01360853 | Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer(ONTRAC) | completed | Phase 3 | 160 | Traws Pharma, Inc.INDUSTRY | 5 | Aug 4, 2016 | clinicaltrials |
| NCT00689715 | Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas(EUS-EP) | unknown | Phase 2 / Phase 3 | 50 | Asan Medical CenterOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT01494506 | Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer(NAPOLI-1) | completed | Phase 3 | 417 | Merrimack PharmaceuticalsINDUSTRY | 15 | Jun 17, 2016 | clinicaltrials |
| NCT00574275 | Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer(VANILLA) | terminated | Phase 3 | 546 | SanofiINDUSTRY | 24 | Jun 7, 2016 | clinicaltrials |
| NCT00417209 | Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen(PAPRIKA) | completed | Phase 3 | 408 | SanofiINDUSTRY | 21 | Jun 3, 2016 | clinicaltrials |
| NCT00416507 | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 190 | Federation Francophone de Cancerologie DigestiveOTHER | 0 | May 30, 2016 | clinicaltrials |
| NCT00602745 | S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen(S-1 Pancreas) | terminated | Phase 3 | 61 | SanofiINDUSTRY | 17 | May 26, 2016 | clinicaltrials |
| NCT00994110 | Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess | completed | Phase 3 | 439 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 1, 2016 | clinicaltrials |
| NCT00634725 | Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 3 | 820 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT00075686 | S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer | completed | Phase 3 | 766 | SWOG Cancer Research NetworkNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00561990 | Nimotuzumab in Adults With Pancreatic Cancer | completed | Phase 2 / Phase 3 | 188 | Oncoscience AGINDUSTRY | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00031837 | Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | terminated | Phase 3 | 400 | Gary MorrowOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00279292 | Randomized Trial of EUS Neurolysis in Pancreas Cancer | completed | Phase 3 | 26 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Oct 14, 2015 | clinicaltrials |
| NCT01598584 | Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT01419002 | Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer(Net-Pac) | terminated | Phase 3 | 5 | CHIR-NetNETWORK | 1 | Jul 29, 2015 | clinicaltrials |
| NCT02510066 | Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain | unknown | Phase 3 | 62 | Shanghai Cancer Hospital, ChinaOTHER | 1 | Jul 28, 2015 | clinicaltrials |
| NCT01521702 | NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer(NEOPAC) | completed | Phase 3 | 2 | Institut Paoli-CalmettesOTHER | 1 | Mar 20, 2015 | clinicaltrials |
| NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer(GIP-2) | unknown | Phase 3 | 310 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT00785421 | Chemotherapy With or Without Enoxaparin in Pancreatic Cancer(PROSPECT) | completed | Phase 2 / Phase 3 | 312 | CONKO-StudiengruppeOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | unknown | Phase 2 / Phase 3 | 1 | Assiut UniversityOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01731821 | Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy | completed | Phase 3 | 308 | Fudan UniversityOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT01121848 | Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer | completed | Phase 3 | 108 | SanofiINDUSTRY | 1 | Oct 27, 2014 | clinicaltrials |
| NCT01586611 | A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer(Panc001) | unknown | Phase 3 | 175 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01362582 | Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer(PANUSCO) | terminated | Phase 3 | 32 | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01214720 | A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | completed | Phase 3 | 607 | Hoffmann-La RocheINDUSTRY | 21 | Aug 13, 2014 | clinicaltrials |
| NCT00679913 | Standardization of Surgery on the Pancreatic Cancer | completed | Phase 3 | 244 | Seoul National University HospitalOTHER | 1 | Jun 6, 2014 | clinicaltrials |
| NCT01479803 | Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS(PICORE) | completed | Phase 3 | 80 | VANBIERVLIETOTHER | 1 | Apr 23, 2014 | clinicaltrials |
| NCT02118077 | Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer(PC6) | completed | Phase 3 | 154 | Cancer Advances Inc.INDUSTRY | 0 | Apr 21, 2014 | clinicaltrials |
| NCT00044031 | Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma | completed | Phase 3 | 394 | Cancer Advances Inc.INDUSTRY | 0 | Apr 17, 2014 | clinicaltrials |
| NCT00303758 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 202 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Mar 4, 2014 | clinicaltrials |
| NCT01065870 | Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) | unknown | Phase 2 / Phase 3 | 64 | Columbia UniversityOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 3 | 1,030 | Royal Liverpool University HospitalOTHER_GOV | 13 | Dec 18, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jan 25, 2019source: clinicaltrials